1. Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
   Ali N. Kamali et al, 2023, Therapeutic Advances in Vaccines and Immunotherapy CrossRef
2. Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7–H4 expression through the MEK/ERK signaling pathway
   Zhiming Zhao et al, 2020, Cancer Letters CrossRef
3. B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas
   Fengyuan Che et al, 2018, International Immunopharmacology CrossRef
4. Immune evasion in renal cell carcinoma: biology, clinical translation, future directions
   Xiaoyang Wang et al, 2021, Kidney International CrossRef
5. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis
   Zhibo Tan et al, 2017, Oncotarget CrossRef
6. B7-H4 expression is upregulated by PKCδ activation and contributes to PKCδ-induced cell motility in colorectal cancer
   Bin Zhou et al, 2022, Cancer Cell International CrossRef
7. Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10
   Fengyuan Che et al, 2017, Cancer Immunology, Immunotherapy CrossRef
8. Could B7-H4 serve as a target to activate anti-cancer immunity?
   Lijuan Wang et al, 2016, International Immunopharmacology CrossRef
9. Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
   Elizabeth C. Wescott et al, 2024, Cancer Research Communications CrossRef
10. Potential targeting of B7‐H4 for the treatment of cancer
    Joseph R. Podojil et al, 2017, Immunological Reviews CrossRef
11. Generation of avian-derived anti-B7-H4 antibodies exerts a blockade effect on the immunosuppressive response
    Tsai-Yu Lin et al, 2021, Experimental Animals CrossRef
12. New checkpoints in cancer immunotherapy
    Ling Ni et al, 2017, Immunological Reviews CrossRef
13. Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma
    Joseph R. Podojil et al, 2020, OncoImmunology CrossRef
14. Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
    Paolo D’Arrigo et al, 2020, Current Medicinal Chemistry CrossRef
15. Tumor immune checkpoints and their associated inhibitors
    Zerui Gao et al, 2022, Journal of Zhejiang University-SCIENCE B CrossRef
16. Cytokines in the Management of Advanced Renal Cell Cancer
    Radha Verman et al, 2015, Kidney Cancer CrossRef
17. New B7 Family Checkpoints in Human Cancers
    Ling Ni et al, 2017, Molecular Cancer Therapeutics CrossRef
18. Advances of Immune Checkpoint Inhibitors in Tumor Immunotherapy
    Qiao Guo, 2018, IOP Conference Series: Materials Science and Engineering CrossRef
19. B7-H4, a promising target for immunotherapy
    Jia-Yu Wang et al, 2020, Cellular Immunology CrossRef